Daniel D. Lantvit

3.5k total citations · 1 hit paper
88 papers, 2.8k citations indexed

About

Daniel D. Lantvit is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel D. Lantvit has authored 88 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 17 papers in Pharmacology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel D. Lantvit's work include Ovarian cancer diagnosis and treatment (11 papers), Natural product bioactivities and synthesis (11 papers) and Microbial Natural Products and Biosynthesis (10 papers). Daniel D. Lantvit is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Natural product bioactivities and synthesis (11 papers) and Microbial Natural Products and Biosynthesis (10 papers). Daniel D. Lantvit collaborates with scholars based in United States, Vietnam and Indonesia. Daniel D. Lantvit's co-authors include John M. Pezzuto, Joanna E. Burdette, Steven M. Swanson, Richard C. Moon, Konstantin Christov, A. Douglas Kinghorn, Rajendra G. Mehta, Krishna Bhat, Heebyung Chai and Esperanza J. Carcache de Blanco and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Daniel D. Lantvit

85 papers receiving 2.7k citations

Hit Papers

Macrophage-derived Osteopontin (SPP1) Protects From Nonal... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel D. Lantvit United States 31 1.4k 364 339 315 309 88 2.8k
Anjana Bhardwaj United States 17 1.4k 1.0× 157 0.4× 377 1.1× 149 0.5× 186 0.6× 37 2.6k
Yoav Sharoni Israel 37 2.0k 1.4× 332 0.9× 270 0.8× 464 1.5× 104 0.3× 90 4.0k
Devivasha Bordoloi India 30 1.9k 1.3× 310 0.9× 425 1.3× 282 0.9× 621 2.0× 50 3.7k
Michael Danilenko Israel 31 2.0k 1.4× 330 0.9× 259 0.8× 435 1.4× 117 0.4× 71 3.5k
Dong Xiao China 34 2.8k 1.9× 430 1.2× 451 1.3× 419 1.3× 400 1.3× 88 3.8k
Fumio Furukawa Japan 28 964 0.7× 254 0.7× 275 0.8× 196 0.6× 192 0.6× 163 2.5k
Sujit Nair India 25 1.7k 1.2× 300 0.8× 298 0.9× 277 0.9× 102 0.3× 65 2.7k
Komal Raina United States 32 1.2k 0.9× 278 0.8× 362 1.1× 70 0.2× 389 1.3× 76 2.5k
Rong Hu United States 25 2.2k 1.5× 227 0.6× 371 1.1× 346 1.1× 121 0.4× 44 2.9k
Sankar Nath Sanyal India 24 790 0.6× 118 0.3× 293 0.9× 136 0.4× 515 1.7× 154 2.0k

Countries citing papers authored by Daniel D. Lantvit

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Lantvit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Lantvit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Lantvit more than expected).

Fields of papers citing papers by Daniel D. Lantvit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Lantvit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Lantvit. The network helps show where Daniel D. Lantvit may publish in the future.

Co-authorship network of co-authors of Daniel D. Lantvit

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Lantvit. A scholar is included among the top collaborators of Daniel D. Lantvit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Lantvit. Daniel D. Lantvit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Xiaodong, Romain Désert, Sukanta Das, et al.. (2024). A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 18(3). 101362–101362. 3 indexed citations
2.
Bazioli, Jaqueline Moraes, Daniel D. Lantvit, Samuel K. Kulp, et al.. (2023). Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models. Molecular Pharmaceutics. 20(6). 3049–3059. 3 indexed citations
3.
Zhang, Ziwei, Daniel D. Lantvit, Tal Hirschhorn, et al.. (2023). Probing the Cytotoxic Signaling Induced by Eupenifeldin in Ovarian Cancer Models. Journal of Natural Products. 86(9). 2102–2110. 1 indexed citations
4.
Han, Hui, Xiaodong Ge, Sai Santosh Babu Komakula, et al.. (2023). Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis. Gastroenterology. 165(1). 201–217. 69 indexed citations breakdown →
5.
Ge, Xiaodong, Romain Désert, Fernando Magdaleno, et al.. (2023). Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice. Journal of Hepatology. 80(3). 482–494. 15 indexed citations
6.
Das, Sukanta, Zhuolun Song, Hui Han, et al.. (2022). Intestinal Osteopontin Protects From Alcohol-induced Liver Injury by Preserving the Gut Microbiome and the Intestinal Barrier Function. Cellular and Molecular Gastroenterology and Hepatology. 14(4). 813–839. 21 indexed citations
7.
Das, Sukanta, Xiaodong Ge, Hui Han, et al.. (2021). The Integrated “Multiomics” Landscape at Peak Injury and Resolution From Alcohol‐Associated Liver Disease. Hepatology Communications. 6(1). 133–160. 11 indexed citations
8.
Russo, Angela, Daniel D. Lantvit, Cedric J. Pearce, et al.. (2020). Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage. Molecular Cancer Therapeutics. 19(1). 89–100. 19 indexed citations
9.
Young, Alexandria N., Daniel D. Lantvit, Christopher C. Coss, et al.. (2018). Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition. Molecular Cancer Therapeutics. 17(10). 2123–2135. 29 indexed citations
11.
Endsley, Michael P., et al.. (2015). Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors. Frontiers in Oncology. 5. 154–154. 19 indexed citations
12.
Sunoqrot, Suhair, Jason Bugno, Daniel D. Lantvit, Joanna E. Burdette, & Seungpyo Hong. (2014). Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles. Journal of Controlled Release. 191. 115–122. 122 indexed citations
13.
Quartuccio, Suzanne M., Daniel D. Lantvit, Maarten C. Bosland, & Joanna E. Burdette. (2013). Conditional Inactivation of p53 in Mouse Ovarian Surface Epithelium Does Not Alter MIS Driven Smad2-Dominant Negative Epithelium-Lined Inclusion Cysts or Teratomas. PLoS ONE. 8(5). e65067–e65067. 17 indexed citations
14.
Ren, Yulin, Susan Matthew, Daniel D. Lantvit, et al.. (2011). Cytotoxic and NF-κB Inhibitory Constituents of the Stems of Cratoxylum cochinchinense and Their Semisynthetic Analogues. Journal of Natural Products. 74(5). 1117–1125. 61 indexed citations
15.
Shen, Qi, Daniel D. Lantvit, Qing Lin, et al.. (2007). Advanced Rat Mammary Cancers Are Growth Hormone Dependent. Endocrinology. 148(10). 4536–4544. 48 indexed citations
16.
Overk, Cassia, Irida Kastrati, Daniel D. Lantvit, et al.. (2007). Structure–Activity Relationships for a Family of Benzothiophene Selective Estrogen Receptor Modulators Including Raloxifene and Arzoxifene. ChemMedChem. 2(10). 1520–1526. 34 indexed citations
17.
Gills, Joell J., Jerome W. Kosmeder, R C Moon, Daniel D. Lantvit, & John M. Pezzuto. (2005). Effect of Deguelin on UVB-Induced Skin Carcinogenesis. Journal of Chemotherapy. 17(3). 297–301. 9 indexed citations
18.
Gills, Joell J., Elizabeth H. Jeffery, Nathan V. Matusheski, et al.. (2005). Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Letters. 236(1). 72–79. 96 indexed citations
19.
Christov, Konstantin, R C Moon, Daniel D. Lantvit, et al.. (2004). Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies. European Journal of Cancer. 40(9). 1404–1411. 11 indexed citations
20.
Constantinou, Andreas I., Daniel D. Lantvit, Michael Hawthorne, et al.. (2001). Chemopreventive Effects of Soy Protein and Purified Soy Isoflavones on DMBA-Induced Mammary Tumors in Female Sprague-Dawley Rats. Nutrition and Cancer. 41(1-2). 75–81. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026